← Back to all trials
Recruiting
NCT07064135
Improved Medication and Care to Achieve Lipid Targets After Carotid Surgery
Conditions: Dyslipidaemias, Carotid Artery Stenoses
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 50
Sponsor: Barmherzige Brüder Linz
Location: Konventhospital Barmherzige Brüder Linz Upper Austria
Summary
The goal of this clinical trial is to find out if patients who receive extra support stay on their cholesterol-lowering therapy and therefore have lower cholesterol levels after 4 months. Extra support means regular phone calls and close monitoring before and after carotid artery surgery. The study compares this approach to usual care.
Participants will:
Be randomly assigned to either standard care or extra support for 4 months. Receive cholesterol-lowering treatment and attend follow-up visits.
Eligibility Criteria
Inclusion Criteria:
* Age \>17 years
* Diagnosed carotid artery stenosis
* Planned carotid endarterectomy
* LDL cholesterol \>55 mg/dL
* Willingness to participate, documented by written informed consent
Exclusion Criteria:
* Ongoing treatment with PCSK9 inhibitors
* Carotid surgery for reasons other than stenosis (e.g., traumatic injury)
Source: ClinicalTrials.gov (NCT07064135). StuddyBuddy aggregates publicly available trial information.